Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barre syndromes
Version 2 2024-06-04, 06:22Version 2 2024-06-04, 06:22
Version 1 1998-12-01, 00:00Version 1 1998-12-01, 00:00
journal contribution
posted on 2024-06-04, 06:22 authored by S Goffette, A Jeanjean, F Pierret, A Peeters, CJM SindicClinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barre syndromes
History
Location
ItalyLanguage
EnglishPublication classification
CN.1 Other journal articleJournal
ACTA NEUROLOGICA BELGICAVolume
98Pagination
322-326ISSN
0300-9009eISSN
2240-2993Issue
4Publisher
SPRINGER HEIDELBERGUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC

